Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/17005
Title: | Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer | Austin Authors: | John, Thomas ;Bowden, Jeffrey J;Clarke, Stephen;Fox, Stephen B;Garrett, Kerryn;Horwood, Keith;Karapetis, Christos S | Affiliation: | Austin Health, Heidelberg, Victoria, Australia Flinders Medical Centre and Flinders University, South Australia, Australia Royal North Shore Hospital, New South Wales, Australia Peter MacCallum Cancer Centre and the University of Melbourne, Melbourne, Victoria, Australia Australian Clinical Labs, Subiaco, West Australia, Australia Icon Cancer Care, South Brisbane, Queensland, Australia |
Issue Date: | Aug-2017 | Date: | 2017-07-12 | Publication information: | Asia-Pacific Journal of Clinical Oncology 2017; 13(4): 296-303 | Abstract: | First-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are used as first-line therapy in patients with non-small cell lung cancer (NSCLC) harboring a sensitizing mutation in the EGFR gene. Unfortunately, resistance to these therapies often occurs within 10 months of commencing treatment and is mostly commonly due to the development of the EGFR T790M mutation. Treatment with the third-generation EGFR TKI, osimertinib can prolong progression free survival in patients with the T790M mutation, so it is important to determine the resistance mechanism in order to plan ongoing therapeutic strategies. Here we review the evidence and make recommendations for the timing of T790M mutation testing, the most appropriate specimens to test and the available testing methods in patients progressing during treatment with first line EGFR TKIs for NSCLC. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/17005 | DOI: | 10.1111/ajco.12699 | Journal: | Asia-Pacific Journal of Clinical Oncology | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/28699260 | Type: | Journal Article | Subjects: | EGFR TKI T790M mutation |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.